Why the study?
What is the risk of generalized tonic-clonic seizures associated with clozapine treatment?
Population
1,418 patients treated with clozapine in the United States between 1972 and 1988
Design
Cohort
Follow-up
up to 3.8 years
Authors
Discussion
Loading...
Member takes
Implication
May warrant enhanced seizure monitoring at higher clozapine doses; extends observational data on cumulative incidence.
Key Points
- To determine the incidence, cumulative risk, dose relationship, and clinical management of seizures occurring in patients treated with clozapine for schizophrenia.
- Retrospective cohort analysis of clinical records from N=1,418 patients receiving clozapine in the United States between 1972 and 1988.
- Assessed generalized tonic-clonic seizure incidence across dose tiers (<300 mg/day, 300–600 mg/day, and ≥600 mg/day) and estimated cumulative risk via life-table analysis.
- Generalized tonic-clonic seizures occurred in 41 of 1,418 patients (2.8%), with life-table analysis projecting a 10% cumulative seizure risk after 3.8 years of treatment.
- Seizure incidence exhibited a dose-dependent relationship, occurring in 4.4% of patients receiving ≥600 mg/day, 2.7% receiving 300–600 mg/day, and 1.0% receiving <300 mg/day, with rapid titration also increasing risk.
- Clozapine treatment was successfully sustained in 31 of 41 patients following a seizure through dose reduction or the addition of an antiepileptic drug.
Structured PICO
What is the risk of generalized tonic-clonic seizures associated with clozapine treatment?
P
Population
1,418 patients treated with clozapine in the United States between 1972 and 1988
I
Intervention
Clozapine (low dose <300 mg/day, medium dose 300-600 mg/day, high dose ≥600 mg/day)
O
Outcome
Generalized tonic-clonic seizuressafety
Clozapine treatment is associated with a dose-dependent risk of generalized tonic-clonic seizures, though most patients can continue therapy with dose reduction or antiepileptic addition.
Cite This Study
Devinsky et al. (1991) studied this question.